Drug intelligence / Profile preview

Nucleo CMP Forte

Development stage
Phase 3
Lead developer
Ferrer
Modality
Small Molecules
Administration
Oral, Intramuscular
01

Overview

Nucleo CMP Forte is a combination drug composed primarily of cytidine-5'-monophosphate (CMP) and uridine-5'-triphosphate (UTP), both sodium salts. Some formulations may also include other nucleotides such as uridine monophosphate (UMP) and uridine diphosphate (UDP)[2][4][8]. It is used as a dietary supplement or adjuvant therapy to support nerve health, muscle function, and cellular metabolism. The mechanism of action involves providing essential nucleotide precursors for the synthesis of nucleic acids (DNA/RNA), phospholipids, sphingomyelin, and glycolipids—key components in neuronal membranes and myelin sheaths[2][4][6]. This supports nerve regeneration and repair processes. Clinical uses include management of peripheral neuropathies such as diabetic polyneuropathy, carpal tunnel syndrome, facial palsy, trigeminal neuralgia, progressive spastic paraparesis, lumbosciatalgia, multiple sclerosis-related symptoms, chronic fatigue syndromes associated with neurological dysfunctions[1][4][5][6][7][8]. The product has shown benefit in improving neurological symptoms in these conditions.

Brand names
Nucleo CMP ForteNucleo C.M.P. ForteNucleo-CMP
Other names
cytidine-5'-monophosphate + uridine-5'-triphosphateNucleo-CMP
02

Targets

P2RY2 (P2Y Purinoceptor 2)Phospholipid biosynthesis enzymes

Beyond the preview

Go deeper on Nucleo CMP Forte.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nucleo CMP Forte.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call